Adaptive Immune Resistance at the Tumour Site: Mechanisms and Therapeutic Opportunities

The authors discuss why defining adaptive immune resistance mechanisms at the tumour site should be a key focus to direct future drug development as well as practical approaches to improve current cancer therapy.